Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6072183

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O[C@H]1CNC[C@@H]1N1CCN(Cc2ccccn2)CC1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR6 P46095 1/20 0.50
KDM4E B2RXH2 9/20 0.49
ALDH1A1 P00352 8/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
LMNA P02545 1/20 0.47
GFER P55789 1/20 0.47
TRPV6 Q9H1D0 1/20 0.46
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PKM P14618 1/20 0.44
CPB2 Q96IY4 1/20 0.43
CYP2C19 P33261 2/20 0.42
CYP1A2 P05177 1/20 0.42
KMT2A Q03164 1/20 0.42
F2 P00734 1/20 0.42
F10 P00742 1/20 0.42
PRSS1 P07477 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6071622 0.85 ALDH1A1 (0.44) KDM4EALDH1A1LMNASMN1; SMN2KMT2A
Trifluoroacetic Acid SCHEMBL6071803 0.82 KDM4E (0.45) KDM4EALDH1A1L3MBTL1MAPK1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL6645611 0.80 ALDH1A1 (0.56) GPR6KDM4EALDH1A1L3MBTL1NPSR1
Trifluoroacetic Acid SCHEMBL6071817 0.79 FAAH (0.43) KDM4EMAPK1CYP2C19
Trifluoroacetic Acid SCHEMBL6072022 0.78 SLC18A3 (0.44)
Trifluoroacetic Acid SCHEMBL6071748 0.78 PLA2G7 (0.44) KDM4EALDH1A1KMT2APOLB
Trifluoroacetic Acid SCHEMBL6071881 0.78 LMNA (0.46) ALDH1A1NPSR1LMNAMAPTMAPK1
Trifluoroacetic Acid SCHEMBL6072071 0.76 SLC18A3 (0.62) MAPK1
Trifluoroacetic Acid SCHEMBL6071601 0.76 LMNA (0.48) KDM4EALDH1A1LMNAMAPTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL6071920 0.75 HSD11B1 (0.53) NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060189628-A1 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189628-A1 Compounds useful as chemokine receptor antagonists ACKR3, CCR5, CXCR2 GPR6 111/4885KDM4E 4629/4885ALDH1A1 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.